Agios Pharmaceuticals | AGIO - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
AbbVie USD 9.39B 4.16B 2026-03
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Amgen USD 12.04B 2.91B 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 6.67B 774M 2025-12
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Daiichi Sankyo JPY 449.81B 92.35B 2026-03
Eli Lilly USD 5.28B 1.99B 2026-03
Exelixis USD 226.15M 256.34M 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Merck USD 5.33B 9.24B 2026-03
Moderna USD 1.72B 185M 2026-06
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novartis USD 7.62B 739M 2026-06
Novartis USD 6.88B 2.68B 2026-03
Pfizer USD 1.7B 561M 2026-03
Puma Biotechnology USD 53.52M 1.14M 2025-09
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03